Patents by Inventor Laurie Von Melchner

Laurie Von Melchner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHENOXY-PIPERIDINES FOR THE TREATMENT OF DISEASES SUCH AS SCHIZOPHRENIA AND DEPRESSION
    Publication number: 20090247584
    Abstract: Compounds of the formula (I), in which R1, R2?, R2?, R2??, R3 and n are as defined in Claim 1, are effectors of the nicotinic and/or muscarinic acetylcholine receptor and are suitable for the prophylaxis or treatment of schizophrenia, depression, anxiety states, dementia, Alzheimer's disease, Lewy bodies dementia, neurodegenerative diseases, Parkinson's disease, Huntington's disease, Tourette's syndrome, learning and memory impairments, age-related memory impairment, amelioration of withdrawal symptoms in nicotine dependence, strokes or brain damage by toxic compounds.
    Type: Application
    Filed: February 26, 2009
    Publication date: October 1, 2009
    Inventors: Gunter HOLZEMANN, Helmut Prucher, Kai Schiemann, Joachim Leibrock, Hartmut Greiner, Christa Burger, Laurie von Melchner
  • Human pyruvate dehydrogenese phosphatase
    Patent number: 7250279
    Abstract: hPDP polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing hPDP polypeptides and polynucleotides in diagnostic assays.
    Type: Grant
    Filed: April 6, 2001
    Date of Patent: July 31, 2007
    Assignee: Merck Patent GmbH
    Inventors: Izaak Den Daas, Michael Gassen, Joachim Leibrock, Laurie Von Melchner
  • Phenoxy piperidines for treating diseases such as schizophrenia and depression
    Publication number: 20050131021
    Abstract: Compounds of the formula (1), in which R1, R2?, R2?, R2??, R3 and n are as defined in claim 1, are effectors of the nicotinic and/or muscarinic acetylcholine receprot and are suitable for the prophylaxis or treatment of schizophrenia, depression, anxiety states, dementia, Alzheimer's disease, Lewy bodies dementia, neurodegenerative diseases, Parkinson's disease, Huntington's disease, Tourette's syndrome, learning and memory impairments, age-related memory impairment, amelioration of withdrawal symptoms in nicotine dependence, strokes or brain damage by toxic compounds.
    Type: Application
    Filed: December 17, 2002
    Publication date: June 16, 2005
    Applicant: Merck Patent GmbH
    Inventors: Gunter Holzemann, Helmut Prucher, Kai Schiemann, Joachim Leibrock, Hartmut Greiner, Christa Burger, laurie von Melchner
  • Human pyruvate dehydrogenese phosphatase
    Publication number: 20030186264
    Abstract: hPDP polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing hPDP polypeptides and polynucleotides in diagnostic assays.
    Type: Application
    Filed: October 4, 2002
    Publication date: October 2, 2003
    Inventors: Izaakden Daas, Michael Gassen, Joachim Leibrock, Laurie von Melchner